BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 31511014)

  • 1. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
    Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
    J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M; Liao X; Li L; Li G; Chen M
    Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
    Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
    Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.
    Wang DX; Zou YJ; Zhuang XB; Chen SX; Lin Y; Li WL; Lin JJ; Lin ZQ
    Acta Pharmacol Sin; 2017 Feb; 38(2):241-251. PubMed ID: 27890917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK3β overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells.
    Zeng J; Liu D; Qiu Z; Huang Y; Chen B; Wang L; Xu H; Huang N; Liu L; Li W
    PLoS One; 2014; 9(3):e91231. PubMed ID: 24618715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
    Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
    Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing NACK by siRNA inhibits tumorigenesis in non-small cell lung cancer via targeting Notch1 signaling pathway.
    Kong R; Feng J; Ma Y; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Zhang T; Zang Q; He X
    Oncol Rep; 2016 Apr; 35(4):2306-14. PubMed ID: 26782286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled oestrogen receptor promotes cell growth of non-small cell lung cancer cells via YAP1/QKI/circNOTCH1/m6A methylated NOTCH1 signalling.
    Shen Y; Li C; Zhou L; Huang JA
    J Cell Mol Med; 2021 Jan; 25(1):284-296. PubMed ID: 33237585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.
    Singh T; Katiyar SK
    PLoS One; 2013; 8(4):e60749. PubMed ID: 23580348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation.
    Huang D; Wang S; Wang A; Chen X; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):788-94. PubMed ID: 27521796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
    Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
    Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3β complex.
    Shi X; Zhao Y; Fan C
    J Cell Mol Med; 2019 Feb; 23(2):1014-1021. PubMed ID: 30417576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
    Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
    Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot characterization of human lung NSCLC by protein pathway activation mapping.
    Zupa A; Improta G; Silvestri A; Pin E; Deng J; Aieta M; Musto P; Nitti D; Mammano E; Liotta L; Belluco C; Wulfkuhle J; Petricoin E
    J Thorac Oncol; 2012 Dec; 7(12):1755-1766. PubMed ID: 23154546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.